000 01492 a2200397 4500
005 20250513160548.0
264 0 _c19990128
008 199901s 0 0 eng d
022 _a0960-894X
024 7 _a10.1016/s0960-894x(98)00377-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHanessian, S
245 0 0 _aProbing the importance of spacial and conformational domains in captopril analogs for angiotensin converting enzyme activity.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_cAug 1998
300 _a2123-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAngiotensin-Converting Enzyme Inhibitors
_xchemistry
650 0 4 _aAnimals
650 0 4 _aCaptopril
_xanalogs & derivatives
650 0 4 _aDrug Design
650 0 4 _aIndicators and Reagents
650 0 4 _aIsomerism
650 0 4 _aLung
_xenzymology
650 0 4 _aModels, Molecular
650 0 4 _aMolecular Conformation
650 0 4 _aPeptidyl-Dipeptidase A
_xisolation & purification
650 0 4 _aProline
_xanalogs & derivatives
650 0 4 _aRabbits
650 0 4 _aRamipril
_xanalogs & derivatives
650 0 4 _aStructure-Activity Relationship
700 1 _aReinhold, U
700 1 _aSaulnier, M
700 1 _aClaridge, S
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 8
_gno. 16
_gp. 2123-8
856 4 0 _uhttps://doi.org/10.1016/s0960-894x(98)00377-1
_zAvailable from publisher's website
999 _c9835916
_d9835916